| Literature DB >> 35410448 |
Izabella Myśliwy1, Agnieszka Perec-Matysiak1, Joanna Hildebrand2.
Abstract
In recent decades, populations of the raccoon (Procyon lotor) and the raccoon dog (Nyctereutes procyonides) have increased and adapted to peri-urban and urban environments in many parts of the world. Their ability to rapidly colonize new territories, high plasticity and behavioral adaptation has enabled these two species to be considered two of the most successful invasive alien species. One of the major threats arising from continually growing and expanding populations is their relevant role in maintaining and transmitting various vector-borne pathogens among wildlife, domestic animals and humans. According to the WHO, over 17% of infectious diseases are vector-borne diseases, including those transmitted by ticks. Every year tick-borne pathogens (TBPs) create new public health challenges. Some of the emerging diseases, such as Lyme borreliosis, anaplasmosis, ehrlichiosis, babesiosis and rickettsiosis, have been described in recent years as posing important threats to global health. In this review we summarize current molecular and serological data on the occurrence, diversity and prevalence of some of the TBPs, namely Babesia, Theileria, Hepatozoon, Borrelia, Rickettsia, Bartonella, Anaplasma and Ehrlichia, that have been detected in raccoons and raccoon dogs that inhabit their native habitats and introduced areas. We draw attention to the limited data currently available on these invasive carnivores as potential reservoirs of TBPs in different parts of the world. Simultaneously we indicate the need for more research in order to better understand the epidemiology of these TBPs and to assess the future risk originating from wildlife.Entities:
Keywords: Invasive species; Nyctereutes procyonides; Procyon lotor; Raccoon; Raccoon dog; Tick-borne pathogens; Vector-borne pathogens; Wildlife
Mesh:
Year: 2022 PMID: 35410448 PMCID: PMC8996218 DOI: 10.1186/s13071-022-05245-3
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Tick-borne pathogens of parasitic and bacterial origin detected in raccoon (Procyon lotor) in its native and introduced range
| TBPs | Species/genospecies | Locality | Prevalence | Diagnostic test | References |
|---|---|---|---|---|---|
| USA-native | 1/1 (100%) | PCR | [ | ||
| Japan-introduced | 2/24 (8.3%) | PCR | [ | ||
| USA-native | 1/1 (100%) | PCR | [ | ||
| USA-native | 34/41 (84%) | PCR | [ | ||
| 37/41 (90%) | |||||
| Japan-introduced | 6/348 (1.7%) | PCR | [ | ||
| 0/348 | |||||
| 0/348 | |||||
| USA-native | 14/17 (82.4%) | PCR | [ | ||
| Austria-introduced | 0/4 | PCR | [ | ||
| USA-native | 70/106 (66%) | PCR | [ | ||
| 11/106 (10%) | |||||
| USA/Canada | 490/699 (70%) | PCR | [ | ||
| 170/699 (24%) | |||||
| USA-native | 5/15(33.3%) | PCR | [ | ||
| USA-native | 0/3 | PCR | [ | ||
| Spain-introduced | 0/2 | PCR | [ | ||
| 0/2 | |||||
| USA-native | 4/4 (100%) | PCR | [ | ||
| Spain-introduced | 5/194 (2.57%) | PCR | [ | ||
| USA-native | 3/15 (20%) | PCR | [ | ||
| Spain-introduced | 0/2 | PCR | [ | ||
| 0/2 | |||||
| 0/2 | |||||
| USA-native | 1/21 (4.8%) | IFAT | [ | ||
| USA-native | 75/370 (20%) | ELISA | [ | ||
| USA-native | 23/87 (26%) | IFAT | [ | ||
| USA-native | 9/200 (4.5%) | IFAT | [ | ||
| USA-native | IFAT 69/156 (44.23%) | IFAT/PCR | [ | ||
| PCR 0/169 | |||||
| Japan-introduced | 1/752 (0.1%) | IIA | [ | ||
| 1/752 (0.1%) | |||||
| USA-native | 1/19 (5.3%) | IFAT | [ | ||
| USA-native | 0/30 | IFAT | [ | ||
| USA-native | 2/25 (8%) | Immunobloting | [ | ||
| USA-native | 1/39 (2.6%) | PCR | [ | ||
| 0/39 | |||||
| USA-native | 17/94 (18.1%) | CF | [ | ||
| USA-native | 35/129 (27.1%) | IFAT | [ | ||
| 8/129 (6.2%) | |||||
| 9/129 (6.9%) | |||||
| USA-native | 55/120 (45.8%) | micro-IF | [ | ||
| 1/120 (0.8%) | |||||
| 2/120 (1.7%) | |||||
| USA-native | 3/14 (21.4%) | MAT | [ | ||
| Japan-introduced | 11/699 (1.6%) | PCR | [ | ||
| 1/699 (0.1%) | |||||
| 1/699 (0.1%) | |||||
| USA-native | 0/9 | IFAT | [ | ||
| Japan-introduced | 14/752 (1.9%) | IIA | [ | ||
| 39/752 (5.2%) | |||||
| USA-native | 14/19 (73.7%) | IFAT | [ | ||
| Japan-introduced | 3/194 (1.5%) | PCR | [ | ||
| 3/194 (1.5%) | |||||
| 1/194 (0.5%) | |||||
| USA-native | 3/30 (10%) | IFAT | [ | ||
| USA-native | 0/1 | IFAT | [ | ||
| USA-native | 3/39 (7.7%) | PCR | [ | ||
| USA-native | 11/42 (26%) | PCR | [ | ||
| Japan-introduced | 0/977 | PCR | [ | ||
| USA-native | 12/37 (32.4%) | PCR | [ | ||
| 1/37 (2.7%) | |||||
| 0/37 | |||||
| USA-native | 11/186 (5.9%) | PCR | [ | ||
| 3/186 (1.6%) | |||||
| USA-native | 0/39 | PCR | [ | ||
| Canada-native | 1/1 (100%) | PCR | [ | ||
| USA-native | IFAT 51/57 (89.5%) | IFAT/PCR | [ | ||
| PCR 14/57 (24.6%) | |||||
| USA-native | IFAT 1/60 (1.7%) | IFAT/PCR | [ | ||
| PCR 0/60 | |||||
| Japan-introduced | IFAT 1/187 (0.5%) | IFAT/PCR | [ | ||
| PCR 0/9 | |||||
| USA-native | IFAT 1/156 (0.64%) | IFAT/PCR | [ | ||
| PCR 0/169 | |||||
| Japan-introduced | 0/699 | PCR | [ | ||
| 36/699 (5.15%) | |||||
| Austria-introduced | 0/4 | PCR | [ | ||
| Czech Republic-introduced | 0/15 | PCR | [ | ||
| Poland-introduced | 1/78 (1.3%) | PCR | [ | ||
| Germany-introduced | 0/40 | ||||
| USA-native | 15/39 (38.5%) | PCR | [ | ||
| 0/39 | |||||
| USA-native | IFAT 9/43 (21%) | IFAT | [ | ||
| USA-native | IFAT 83/411 (20%) | IFAT/PCR | [ | ||
| PCR 0/20 | |||||
| USA-native | IFAT 13/60 (21.7%) | IFAT/ PCR | [ | ||
| PCR 1/60 (1.7%) | |||||
| IFAT 23/60 (38.3%) | |||||
| PCR 0/60 | |||||
| PCR 0/60 | |||||
| Japan-introduced | IFAT 1/187 (0.5%) | IFAT/PCR | [ | ||
| PCR 0/9 | |||||
| IFAT 3/187 (1.6%) | |||||
| PCR 0/9 | |||||
| USA-native | IFAT 49/156 (31.41%) | IFAT/PCR | [ | ||
| PCR 0/169 | |||||
| IFAT 18/156 (11.53%) | |||||
| PCR 0/169 | |||||
| 0/169 PCR | |||||
| USA-native | 8/19 (42.1%) | IFAT | [ | ||
| Japan-introduced | 0/699 | PCR | [ | ||
| 0/699 | |||||
| Austria-introduced | 0/4 | PCR | [ | ||
| Czech Republic-introduced | 0/15 | PCR | [ | ||
| Spain-introduced | 5/194 (2.57%) | PCR | [ | ||
| USA-native | 0/39 | PCR | [ | ||
| 0/39 | |||||
| 0/39 | |||||
| USA-native | 32/60 (53.3%) | PCR | [ | ||
| USA-native | 131/197 (67%) | PCR | [ | ||
| Czech Republic-introduced | 0/15 | PCR | [ | ||
| Poland-introduced | 0//78 | PCR | [ | ||
| Germany-introduced | 0/40 |
Prevalence and diagnostic tests are included for each reference
CF, Complement-fixing antibodies; ELISA, enzyme-linked immunosorbent assay; IFAT, indirect fluorescent antibody test, IIA, indirect immunoperoxidase assay; MAT, microaglutination antibody test; PCR, polymerase chain reaction
aB. microti-like name was used for all sequences belonging to B. microti group and reported by authors as B. cf. microti
Tick-borne pathogens of parasitic and bacterial origin detected in free-ranging raccoon dogs (Nyctereutes procyonoides) in their native and introduced range
| TBPs | Species/genospecies | Locality | Prevalence | Diagnostic test | References |
|---|---|---|---|---|---|
| South Korea-native | 3/14 (21.4%) | PCR | [ | ||
| South Korea-native | 0/23 | PCR | [ | ||
| Austria-introduced | 5/8 (62.5%) | PCR | [ | ||
| South Korea-native | 0/15 | PCR | [ | ||
| Poland-introduced | 2/28 (25%) | PCR | [ | ||
| 5/28 (62.5%) | |||||
| 1/28 (12.5%) | |||||
| South Korea-native | 1/142 (0.7%) | PCR | [ | ||
| Japan-native | 0/30 | IFAT | [ | ||
| 0/30 | |||||
| South Korea-native | 11/36 (30.5%) | IFAT | [ | ||
| 15/36 (41.6%) | |||||
| South Korea-native | 0/ 15 | PCR | [ | ||
| Japan-native | 0/171 | PCR | [ | ||
| South Korea-native | 2/142 (1.5%) | PCR | [ | ||
| Japan-native | 44/619 (7.1%) | PCR | [ | ||
| Germany-introduced | 3/13 (23.2%) | PCR | [ | ||
| Austria-introduced | 0/8 | PCR | [ | ||
| Czech Republic-introduced | 0/7 | PCR | [ | ||
| South Korea-native | 1/15 (6.6%) | PCR | [ | ||
| Poland-introduced | 0/10 (30%) | PCR | [ | ||
| South Korea-native | 2/193 (1%) 4/193 (2.1%) | PCR | [ | ||
| Poland-introduced | 24/68 (35.3%) | PCR | [ | ||
| South Korea-native | 0/15 | PCR | [ | ||
| Austria-introduced | 0/8 | PCR | [ | ||
| Czech Republic-introduced | 0/7 | PCR | [ | ||
| Austria-introduced | 0/8 | PCR | [ | ||
| Czech Republic-introduced | 0/7 | PCR | [ | ||
| Poland-introduced | 3/10 (30%) | PCR | [ |
Prevalence and diagnostic test are included for each reference
IFAT, indirect fluorescent antibody test, PCR, polymerase chain reaction
aB. microti-like name was used for all sequences belonging to B. microti group and reported by authors as B. cf. microti